Semaglutide will return to pharmacy shelves this month, but the TGA has warned not all patients previously prescribed the GLP-1 receptor agonist will be able to resume treatment immediately.

A surge in off-label prescribing for weight loss led to a worldwide semaglutide shortage, to the extent it was unavailable in Australia from mid-November onwards.